Kathryn G. Link, PhD (she/her/hers)

Manager ClinPh/Pharmacometr(P)
Pharmacometrics & Systems Pharmacology, Translational Clinical Sciences, Pfizer Inc

Poster(s):

• (T-079) A mechanistic QSP model of CRS allows for quantitative assessment of dose priming of CD3 bispecific antibody (BsAb) therapeutics.
  Tuesday, November 12, 2024

  7:00 AM – 5:00 PM MST